PenderFund Capital Management »

Esperion Therapeutics shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 6.7M 2.65
2025-06-30 $6.6M 6.7M 0.98
2025-03-31 $11M 2.0M 5.39

More positions owned by PenderFund Capital Management

First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Abrdn Platinum Etf Trust Physcl Platm Shs (PPLT)
Equinox Gold Corp equities (EQX)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Equinox Gold Corp Note 4.750%10/1 (Principal)
Southern Note 4.500% 6/1 (Principal)
Pdd Holdings Note 12/0 (Principal)
Esperion Therapeutics (ESPR)
Beyond Meat Note 3/1 (Principal)
Nio Note 3.875%10/1 (Principal)
Wolfspeed Note 1.750% 5/0 (Principal)
PAR Technology Corporation (PAR)
Cardlytics Note 4.250% 4/0 (Principal)
Wolfspeed Note 1.875%12/0 (Principal)

View all positions for PenderFund Capital Management

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
PenderFund Capital Management
Geode Capital Management
State Street Corporation
Nuveen
AIGH Capital Management
Marshall Wace
Royce & Associates
Two Sigma Investments
Jane Street
Citadel Advisors
Two Sigma Advisers

View all funds holding Esperion Therapeutics